Chinese Language Podcast: 集采, ADC交易, 基因编辑出口和中国生物制药内在矛盾
Hot topics discussed range from ADC deals and VBP to the China biotech paradox
Executive Summary
Recent major ADC deals, volume-based procurement (Jicai), China’s plan to ban gene-editing technology exports and the biotech paradox in China are the main topics for this new China Biotech Hot Topic podcast. Brian Yang and Dexter Yan discuss key aspects to watch and the implications for major players as well as the wider pharma sector.